Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM2PM5PP3_Strong
The NM_000368.5(TSC1):c.278T>G(p.Leu93Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as not provided (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L93Q) has been classified as Likely pathogenic.
TSC1 (HGNC:12362): (TSC complex subunit 1) This gene is a tumor suppressor gene that encodes the growth inhibitory protein hamartin. The encoded protein interacts with and stabilizes the GTPase activating protein tuberin. This hamartin-tuberin complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. This protein also functions as a co-chaperone for Hsp90 that inhibits its ATPase activity. This protein functions as a facilitator of Hsp90-mediated folding of kinase and non-kinase clients, including TSC2 and thereby preventing their ubiquitination and proteasomal degradation. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
Gain of methylation at L93 (P = 0.0036);Gain of methylation at L93 (P = 0.0036);Gain of methylation at L93 (P = 0.0036);Gain of methylation at L93 (P = 0.0036);Gain of methylation at L93 (P = 0.0036);Gain of methylation at L93 (P = 0.0036);Gain of methylation at L93 (P = 0.0036);Gain of methylation at L93 (P = 0.0036);Gain of methylation at L93 (P = 0.0036);Gain of methylation at L93 (P = 0.0036);Gain of methylation at L93 (P = 0.0036);Gain of methylation at L93 (P = 0.0036);Gain of methylation at L93 (P = 0.0036);Gain of methylation at L93 (P = 0.0036);Gain of methylation at L93 (P = 0.0036);Gain of methylation at L93 (P = 0.0036);